vs
PATHWARD FINANCIAL, INC.（CASH）与CASTLE BIOSCIENCES INC（CSTL）财务数据对比。点击上方公司名可切换其他公司
PATHWARD FINANCIAL, INC.的季度营收约是CASTLE BIOSCIENCES INC的3.3倍（$276.3M vs $83.7M），PATHWARD FINANCIAL, INC.净利率更高（26.4% vs -17.4%，领先43.7%），过去两年PATHWARD FINANCIAL, INC.的营收复合增速更高（21.0% vs -1.9%）
Pathward Financial, Inc.是一家总部位于美国的银行及金融服务企业，其前身为Meta金融集团旗下相关业务主体，2022年母公司将“Meta”商标出售给Meta Platforms后，正式启用现有名称。
Castle Biosciences是一家处于商业阶段的诊断企业，专注于开发和商业化针对黑色素瘤等皮肤癌及罕见病的专利临床诊断检测产品，主要服务美国医疗市场，聚焦未被满足的精准诊断需求领域，辅助临床医生制定治疗决策。
CASH vs CSTL — 直观对比
营收规模更大
CASH
是对方的3.3倍
$83.7M
净利率更高
CASH
高出43.7%
-17.4%
两年增速更快
CASH
近两年复合增速
-1.9%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $276.3M | $83.7M |
| 净利润 | $72.9M | $-14.5M |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | 26.4% | -17.4% |
| 营收同比 | — | -4.9% |
| 净利润同比 | — | 43.8% |
| 每股收益（稀释后） | $3.35 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CASHCSTL
| Q1 26 | $276.3M | $83.7M | ||
| Q4 25 | $173.1M | $87.0M | ||
| Q3 25 | $186.7M | $83.0M | ||
| Q2 25 | $195.8M | $86.2M | ||
| Q1 25 | $274.8M | $88.0M | ||
| Q4 24 | $182.6M | $86.3M | ||
| Q3 24 | $179.5M | $85.8M | ||
| Q2 24 | $188.6M | $87.0M |
净利润CASHCSTL
| Q1 26 | $72.9M | $-14.5M | ||
| Q4 25 | $35.2M | — | ||
| Q3 25 | $38.8M | $-501.0K | ||
| Q2 25 | $42.1M | $4.5M | ||
| Q1 25 | $75.0M | $-25.8M | ||
| Q4 24 | $30.0M | — | ||
| Q3 24 | $33.5M | $2.3M | ||
| Q2 24 | $44.9M | $8.9M |
毛利率CASHCSTL
| Q1 26 | — | — | ||
| Q4 25 | — | 79.0% | ||
| Q3 25 | — | 77.5% | ||
| Q2 25 | — | 79.5% | ||
| Q1 25 | — | 81.4% | ||
| Q4 24 | — | 81.3% | ||
| Q3 24 | — | 81.8% | ||
| Q2 24 | — | 83.3% |
营业利润率CASHCSTL
| Q1 26 | — | — | ||
| Q4 25 | 24.6% | -4.4% | ||
| Q3 25 | 25.9% | -8.2% | ||
| Q2 25 | 24.1% | -4.9% | ||
| Q1 25 | 33.2% | -31.7% | ||
| Q4 24 | 19.8% | 4.7% | ||
| Q3 24 | 20.9% | 5.9% | ||
| Q2 24 | 27.1% | 5.8% |
净利率CASHCSTL
| Q1 26 | 26.4% | -17.4% | ||
| Q4 25 | 20.3% | — | ||
| Q3 25 | 20.8% | -0.6% | ||
| Q2 25 | 21.5% | 5.2% | ||
| Q1 25 | 27.3% | -29.4% | ||
| Q4 24 | 16.4% | — | ||
| Q3 24 | 18.7% | 2.6% | ||
| Q2 24 | 23.8% | 10.3% |
每股收益（稀释后）CASHCSTL
| Q1 26 | $3.35 | $-0.49 | ||
| Q4 25 | $1.57 | $-0.06 | ||
| Q3 25 | $1.69 | $-0.02 | ||
| Q2 25 | $1.81 | $0.15 | ||
| Q1 25 | $3.14 | $-0.90 | ||
| Q4 24 | $1.23 | $0.32 | ||
| Q3 24 | $1.34 | $0.08 | ||
| Q2 24 | $1.78 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $157.6M | $63.8M |
| 总债务越低越好 | $59.5M | $10.1M |
| 股东权益账面价值 | $850.7M | $461.4M |
| 总资产 | $7.1B | $547.8M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资CASHCSTL
| Q1 26 | $157.6M | $63.8M | ||
| Q4 25 | $331.2M | $299.5M | ||
| Q3 25 | $120.6M | $287.5M | ||
| Q2 25 | $258.3M | $275.9M | ||
| Q1 25 | $254.2M | $275.2M | ||
| Q4 24 | $597.4M | $293.1M | ||
| Q3 24 | $158.3M | $95.0M | ||
| Q2 24 | $298.9M | $85.6M |
总债务CASHCSTL
| Q1 26 | $59.5M | $10.1M | ||
| Q4 25 | $33.5M | $10.1M | ||
| Q3 25 | $33.5M | $10.0M | ||
| Q2 25 | $33.4M | $10.0M | ||
| Q1 25 | $33.4M | $10.0M | ||
| Q4 24 | $33.4M | $10.0M | ||
| Q3 24 | $33.4M | $10.0M | ||
| Q2 24 | $33.3M | $10.0M |
股东权益CASHCSTL
| Q1 26 | $850.7M | $461.4M | ||
| Q4 25 | $854.5M | $470.9M | ||
| Q3 25 | $858.0M | $467.0M | ||
| Q2 25 | $819.0M | $455.4M | ||
| Q1 25 | $814.7M | $440.3M | ||
| Q4 24 | $758.3M | $455.8M | ||
| Q3 24 | $822.5M | $441.1M | ||
| Q2 24 | $748.4M | $423.9M |
总资产CASHCSTL
| Q1 26 | $7.1B | $547.8M | ||
| Q4 25 | $7.6B | $578.6M | ||
| Q3 25 | $7.2B | $562.8M | ||
| Q2 25 | $7.2B | $544.7M | ||
| Q1 25 | $7.0B | $501.7M | ||
| Q4 24 | $7.6B | $531.2M | ||
| Q3 24 | $7.5B | $514.6M | ||
| Q2 24 | $7.5B | $487.3M |
负债/权益比CASHCSTL
| Q1 26 | 0.07× | 0.02× | ||
| Q4 25 | 0.04× | 0.02× | ||
| Q3 25 | 0.04× | 0.02× | ||
| Q2 25 | 0.04× | 0.02× | ||
| Q1 25 | 0.04× | 0.02× | ||
| Q4 24 | 0.04× | 0.02× | ||
| Q3 24 | 0.04× | 0.02× | ||
| Q2 24 | 0.04× | 0.02× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-22.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CASHCSTL
| Q1 26 | — | $-22.1M | ||
| Q4 25 | $108.3M | $26.9M | ||
| Q3 25 | $303.7M | $22.6M | ||
| Q2 25 | $30.4M | $20.8M | ||
| Q1 25 | $188.3M | $-6.0M | ||
| Q4 24 | $-71.7M | $24.4M | ||
| Q3 24 | $143.1M | $23.3M | ||
| Q2 24 | $113.2M | $24.0M |
自由现金流CASHCSTL
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $19.7M | ||
| Q3 25 | $300.3M | $7.8M | ||
| Q2 25 | $27.7M | $11.6M | ||
| Q1 25 | $184.7M | $-10.8M | ||
| Q4 24 | $-73.8M | $16.8M | ||
| Q3 24 | $138.8M | $17.0M | ||
| Q2 24 | $111.0M | $18.8M |
自由现金流率CASHCSTL
| Q1 26 | — | — | ||
| Q4 25 | 60.1% | 22.7% | ||
| Q3 25 | 160.9% | 9.4% | ||
| Q2 25 | 14.1% | 13.4% | ||
| Q1 25 | 67.2% | -12.2% | ||
| Q4 24 | -40.4% | 19.5% | ||
| Q3 24 | 77.3% | 19.8% | ||
| Q2 24 | 58.8% | 21.6% |
资本支出强度CASHCSTL
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 8.3% | ||
| Q3 25 | 1.8% | 17.9% | ||
| Q2 25 | 1.4% | 10.7% | ||
| Q1 25 | 1.3% | 5.4% | ||
| Q4 24 | 1.1% | 8.8% | ||
| Q3 24 | 2.4% | 7.4% | ||
| Q2 24 | 1.2% | 6.0% |
现金转化率CASHCSTL
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | — | ||
| Q3 25 | 7.83× | — | ||
| Q2 25 | 0.72× | 4.60× | ||
| Q1 25 | 2.51× | — | ||
| Q4 24 | -2.39× | — | ||
| Q3 24 | 4.27× | 10.29× | ||
| Q2 24 | 2.52× | 2.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CASH
| Noninterest Income | $151.2M | 55% |
| Net Interest Income | $125.1M | 45% |
CSTL
暂无分部数据
